Clinical Significance of Elevation in Neuroendocrine Factors and Interleukin-6 in Metastatic Prostate Cancer

By Hoosein N.   Abdul M.   McCabe R.   Gero E.   Deftos L.   Banks M.   Hodges S.   Finn L.   Logothetis C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 6, 1995-11 ,pp. : 246-251

Elsevier

Access to resources Recommend Favorite

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer

By Madeleine Margaret  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 887-899

Springer Publishing Company

Access to resources Recommend Favorite

The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality

By Berger Franklin  

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 281-285

Springer Publishing Company

Access to resources Recommend Favorite

Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer

By Won Hye Sung   Kim Young Ae   Lee Jun Sang   Jeon Eun Kyoung   An Ho Jung   Sun Der Sheng   Ko Yoon Ho   Kim Jeong Soo  

Cancer Investigation, Vol. 31, Iss. 8, 2013-10 ,pp. : 516-521

Informa Healthcare

Access to resources Recommend Favorite

Soluble interleukin-6 receptor to interleukin-6 (sIL6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy

By                    

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 861-864

Spandidos Publications

Access to resources Recommend Favorite